ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 98 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,965 | -33.9% | 108,900 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,129,293 | +38.5% | 108,900 | +8.0% | 0.00% | 0.0% |
| Q1 2023 | $815,472 | -54.0% | 100,800 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,773,450 | +2.0% | 112,600 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,739,000 | +23.3% | 110,500 | +9.4% | 0.00% | 0.0% |
| Q2 2022 | $1,410,000 | -24.6% | 101,000 | -6.9% | 0.00% | 0.0% |
| Q1 2022 | $1,871,000 | +27.4% | 108,500 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $1,469,000 | -16.1% | 101,000 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $1,750,000 | +2.5% | 97,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,707,000 | +349.2% | 97,200 | +53.3% | 0.00% | – |
| Q1 2019 | $380,000 | -11.4% | 63,400 | +9.3% | 0.00% | -100.0% |
| Q4 2018 | $429,000 | -29.4% | 58,000 | +38.4% | 0.00% | 0.0% |
| Q3 2018 | $608,000 | -27.4% | 41,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $837,000 | +14.0% | 41,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $734,000 | -24.3% | 41,900 | +6.6% | 0.00% | 0.0% |
| Q4 2017 | $969,000 | -4.4% | 39,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,014,000 | +27.5% | 39,300 | +34.1% | 0.00% | 0.0% |
| Q2 2017 | $795,000 | -9.0% | 29,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $874,000 | +9.9% | 29,300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $795,000 | +102.8% | 29,300 | +91.5% | 0.00% | 0.0% |
| Q3 2016 | $392,000 | +38.5% | 15,300 | 0.0% | 0.00% | – |
| Q2 2016 | $283,000 | – | 15,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |